BackBackTotal equity of Viridian Therapeutics, Inc.
Annual data
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
0.00
170.00 M
340.00 M
510.00 M
680.00 M
Period
Value
Change
Change %
2024
671.64 M
+229.62 M
+51.95%
2023
442.02 M
+46.96 M
+11.89%
2022
395.06 M
+207.35 M
+110.46%
2021
187.72 M
+67.68 M
+56.38%
2020
120.04 M
+104.28 M
+661.95%
Quarterly data
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
200.00 M
400.00 M
600.00 M
800.00 M
Period
Value
Change
Change %
Q4 '24
671.64 M
−35.86 M
−5.07%
Q3 '24
707.50 M
+178.16 M
+33.66%
Q2 '24
529.34 M
−53.19 M
−9.13%
Q1 '24
582.53 M
+140.51 M
+31.79%
Q4 '23
442.02 M
+158.45 M
+55.87%
Q3 '23
283.58 M
−32.28 M
−10.22%
Q2 '23
315.86 M
−34.69 M
−9.90%
Q1 '23
350.55 M
−44.52 M
−11.27%